Perseus Proteomics Inc.
USPTO PatentsView assignee record - 16 granted patents across 7 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Perseus ranks #17,994 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 7 technology areas.
- #17,994
- of 49,997 US assignees by volume
- 48th percentile
- by Innovation Score (34.6/100)
- 14.6
- avg claims per patent
- -93%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R17994 · Foreign Corporation #17,994 · 16 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 16 grants
- MID-PACK #17,994/49,997
- PHOTO-FINISH Ovonic Battery
- CPC-NARROW A61P · 7 areas
- INNOV-THIN 34.6/100
- CLAIMS-RICH 14.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -93% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Ovonic Battery Company, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Perseus’s 34.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Perseus
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Perseus Proteomics · this assignee
Perseus Proteomics · this assignee
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Perseus's Innovation Score is 34.6/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Perseus?
Each dot is one of Perseus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Perseus’s own 14.6 claims/patent is ABOVE the 9.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Perseus's grants concentrate
Perseus Proteomics Inc. is a focused PatentsView assignee: 7 CPC subclasses with 87.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2018. By volume, Perseus sits between Ovonic Battery Company, Inc. and Pkware, Inc..
Perseus's three-year grant acceleration
Perseus Proteomics Inc. shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Perseus's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Ovonic Battery
Ovonic Battery Company, Inc.
16 patents
- Pact XPP
Pact XPP Technologies AG
16 patents
- PAO Shen Enterpri…
PAO Shen Enterprises Co., Ltd.
16 patents
- Peacock Apparel G…
Peacock Apparel Group, Inc.
16 patents
- PGI Drug Discovery
PGI Drug Discovery LLC
16 patents
- Pgytech
Pgytech Co., Ltd.
16 patents
- Pharma MAR
Pharma MAR, S.A.
16 patents
- Pkware
Pkware, Inc.
16 patents
- Perseus Proteomics ◀
Perseus Proteomics Inc.
16 patents
What this shows Perseus holds 16 patents at rank #17,981, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Perseus
By rank, the assignees closest to #17,981 in granted patent volume.
- Ovonic Battery Company, Inc. #17,977 · 16 patents
- Pact XPP Technologies AG #17,978 · 16 patents
- PAO Shen Enterprises Co., Ltd. #17,979 · 16 patents
- Peacock Apparel Group, Inc. #17,980 · 16 patents
- PGI Drug Discovery LLC #17,982 · 16 patents
- Pgytech Co., Ltd. #17,983 · 16 patents
- Pharma MAR, S.A. #17,984 · 16 patents
- Pkware, Inc. #17,985 · 16 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Perseus's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Perseus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 48th percentile higher than 48% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 25.0% |
| 2016 | 5 | 31.3% |
| 2017 | 5 | 31.3% |
| 2018 | 1 | 6.3% |
| 2024 | 1 | 6.3% |
Which technologies does Perseus Proteomics Inc. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Perseus Proteomics Inc.'s patent record in context - here's where to go next.
- Perseus Proteomics Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 87.5% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #17,994 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Perseus Proteomics Inc. against Ovonic Battery Company, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 34.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.